New diabetes clinical trial: A Study of MSDC-0602K to Assess Glycemic Control, Resolution of NASH, and Outcomes in Patients With Diabetes and NASH

Published on: May 31, 2019 at 07:00PM
Conditions:   Type2 Diabetes;   NASH - Nonalcoholic Steatohepatitis;   Nonalcoholic Steatohepatitis;   Non-Alcoholic Fatty Liver Disease
Interventions:   Drug: MSDC-0602K;   Drug: Placebo oral tablet
Sponsor:   Cirius Therapeutics, Inc.
Not yet recruiting